Quick Takeaways
- David Dornan has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $41,525.
- Recent insider filing activity is available below.
Insider Trading & Ownership of David Dornan
- Location
- Redwood City, CA
- Summary
- The estimated net worth of David Dornan is at least $41,525 dollars as of 03 Apr 2026. David Dornan is the CHIEF SCIENTIFIC OFFICER of Elevation Oncology, Inc. and owns shares of Elevation Oncology, Inc. stock worth about $41.5K.
- Signature
- /s/ Stephen Rodin, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow David Dornan and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Elevation Oncology, Inc. ($41,525).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of David Dornan
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ELEV | Elevation Oncology, Inc. | Chief Scientific Officer | $41,525 | 15 Feb 2025 | ||
| BOLT | Bolt Biotherapeutics, Inc. | Chief Scientific Officer | 18 Feb 2022 | |||
| WHWK | Whitehawk Therapeutics, Inc. | Chief Scientific Officer | 01 Apr 2026 |
Insider Transactions Reported by David Dornan:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.